Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Tablets × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 5 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Lymphoma 1 Lung Neoplasms 1 Localized Prostate Cancer 1 Leukemia 1 Laryngeal Diseases 1 Inflammation 1

Interventions

palbociclib 1 microcrystalline cellulose 1 epigallocatechin gallate 1 dapagliflozin 1 Tablets 1 Specimen Handling 1 Selenium 1 Saline Solution 1 Pregabalin 1 Platelet Count 1 Plastic Surgery Procedures 1 Omeprazole 1 Losartan 1 Ketorolac 1 Infliximab 1 Immunotherapy, Adoptive 1 Dexmedetomidine 1 Cognitive Behavioral Therapy 1 Bevacizumab 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡